tiprankstipranks
Regeneron price target raised to $800 from $756 at Baird
The Fly

Regeneron price target raised to $800 from $756 at Baird

Baird raised the firm’s price target on Regeneron to $800 from $756 and keeps a Neutral rating on the shares. The analyst raised his target on impressive Dupixent results in COPD and also raised his sales estimates upward based on the data.

Published first on TheFly

See Insiders’ Hot Stocks on TipRanks >>

Read More on REGN:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles